Clinical and laboratory characteristics of influenza infection in hospitalized adult patients during the 2018-2019 epidemic season

Cover Page


Cite item

Full Text

Abstract

Despite the success in prevention and therapy, influenza remains a mass disease with mortality rate up to 0.01—0.2% worldwide.

Purpose. Conducting clinical and laboratory analysis of influenza infection cases and evaluating their etiological significance in adult hospitalized patients during 2018—2019 epidemic season.

Materials and methods. There were analyzed 569 case histories of patients hospitalized at the Clinical Infectious Diseases Hospital named after S.P. Botkin. Patients were examined by PCR that resulted in verified influenza virus in 260 cases. Nasopharyngeal swabs collected from 36 patients were examined by virological method on MDCK cell culture. 24 influenza virus strains were isolated and identified.

Results. The study allowed to identify a viral landscape represented by influenza viruses A and B found in 98.5% and 1.5% cases, respectively. Influenza viruses isolated on cell culture in 50% of cases were identified. Among the influenza viruses isolated on cell culture there were identified serotype A influenza viruses (H1N1) closely related to the pandemic influenza A (H1N1)pdm09. Some isolates (41.7%) belonged to serotype A (H3N2), which were related to strain A/Singapore/16-0019/16. Influenza B virus strain of the Victoria lineage isolated from a hospitalized patient possessed a triple deletion in hemagglutinin gene, which antigenic properties substantially differed from those of the influenza virus strain being included into current influenza vaccines. Upon admission, the condition of most patients was estimated as moderate (males — 48.7%, females — 51.3%). The median patient age was 35 years old, with comorbidities being registered in 50% cases. The clinical picture for 2018—2019 seasonal influenza displayed no distinctive features as compared to previous epidemic seasons. The duration of intoxication and catarrhal syndrome was 4.3±0.13 and 6.9±0.29 days, respectively, with median body temperature ranging within 39.2±0.06°С. All patients received standard pathogenetic therapy. Complications were noted in 86.7% cases such as pneumonia — 11.1%, sinusitis — 6.9%, bronchitis — 56.9%. The bed day length was 5.93±0.29, no lethal outcomes were recorded.

Conclusion. It was found that influenza A viruses were dominant in patients observed comprising up to 98.5% cases, whereas influenza viruses B were found in as few as 1.5% patients. The clinical picture was characterized by severe intoxication and catarrhal syndrome, being frequently associated with complications.

About the authors

L. V. Voloshchuk

St. Petersburg Pasteur Institute

Author for correspondence.
Email: 7970747@mail.ru

Liubov V. Voloshchuk - PhD (Medicine), Senior Researcher.

197101, St. Petersburg, Mira str., 14, Phone: +7 (921) 797-07-47 (mobile)

Russian Federation

A. A. Go

St. Petersburg Pasteur Institute

Email: alexeigo@mail.ru

PhD (Medicine), infectologist.

St. Petersburg

Russian Federation

M. M. Pisareva

Smorodintsev Research Institute of Influenza

Email: maria.pisareva@influenza.spb.ru

PhD Student.

St. Petersburg

Russian Federation

D. A. Guzhov

Smorodintsev Research Institute of Influenza

Email: dimas1992@list.ru

Pisareva M.M., PhD (Medicine), Leading Researcher.

St. Petersburg

Russian Federation

M. A. Bichurina

St. Petersburg Pasteur Institute

Email: romanenkova@pasteurorg.ru

PhD, MD (Medicine), Head of the Virological Laboratory of Measles and Rubella Elimination.

St. Petersburg

Russian Federation

P. A. Petrova

St. Petersburg Pasteur Institute; Smorodintsev Research Institute of Influenza

Email: maria.pisareva@influenza.spb.ru

Researcher, SRII; Researcher, St. Petersburg Pasteur I.

St. Petersburg

Russian Federation

References

  1. Башкетова Н.С., Чхинджерия И.Г., Бичурина М.А., Крайнова Т.И., Брянцева Е.А., Лаврентьева И.Н., Сухобаев-ская Л.П., Дегтярев О.В., Демакова Т.Е. Эпидемический подъем заболеваемости гриппом в Санкт-Петербурге в 2016 году // Инфекция и иммунитет. 2017. Т. 7, № 3. С. 303-308. doi: 10.15789/2220-7619-2017-3-303-308
  2. Гладков С.А., Григорьева И.В., Дедов В.А., Эсауленко Е.В., Цинзерлинг В.А. Клинико-морфологические сопоставления в случаях летальных исходов при гриппе в 2009-2011 гг. // Журнал инфектологии. 2011. T. 3, № 4. С. 55-61. doi: 10.22625/2072-67322011-3-4-55-61
  3. Еженедельный бюллетень по информированному мониторингу проявлений гриппа H1N1 и других генотипов вируса с пандемическим потенциалом за период 09.05.2010-16.06.2010 / ФБУН ГНЦ ВБ «Вектор». № 7.
  4. Жаркин Н.А., Подобед Н.Д. Грипп и вызванная им пневмония у беременных: уроки пандемии // Журнал практического врача акушера-гинеколога. 2010. № 1. С. 11—15.
  5. Манухина Е.Б., Лямина Н.П., Долотовская П.В., Машина С.Ю., Лямина С.В., Покидышев Д.А., Малышев И.Ю. Роль оксида азота и кислородных радикалов в патогенезе артериальной гипертензии // Кардиология. 2002. Т. 42, № 11. С. 73—84.
  6. Покровский В.И., Семенов Б.Ф. Концепция отложенной смерти при гриппе и тактика вакцинопрофилактики инфарктов, инсультов и летальных исходов при этой инфекции // Русский медицинский журнал. 2003. Т. 11, № 22. С. 1266—1268.
  7. Шаханина И.Л. Экономический анализ инфекционных болезней: прошлое, настоящее, будущее // Инфекционные болезни. 2009. Т. 7, № 1. С. 16—19.
  8. Dawood F.S. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med., 2009, vol. 360, no. 25, pp. 2605-2615. doi: 10.1056/NEJMoa0903810
  9. Freeman D.W., Barno A. Deaths from Asian influenza associated with pregnancy. Am. J. Obstet. Gynecol., 1959, vol. 78, no. 6, pp. 1172-1175. doi: 10.1016/0002-9378(59)90570-8
  10. Garnacho-Montero J., Leon-Moya C., Gutierrez-Pizarraya A., Arenzana-Seisdedos A. Vidaur L., Guerrero J.E., Gordon M., Martm-Loeches I., Rodriguez A.; on Behalf GETGAG Study Group. Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit. J. Crit. Care, 2018, vol. 48, pp. 172-177. doi: 10.1016/j.jcrc.2018.08.017
  11. Jochems S.P., Marcon F., Carniel B.F., Holloway M., Mitsi E., Smith E., Gritzfeld J.F., Solorzano C., Reine J., Pojar S., Nikolaou E., German E.L., Hyder-Wright A., Hill H., Hales C., de Steenhuijsen Piters W.A.A., Bogaert D., Adler H., Zaidi S., Connor V., Gordon S.B., Rylance J., Nakaya H.I., Ferreira D.M. Inflammation induced by influenza virus impairs human innate immune control of pneumococcus. Nat. Immunol., 2018, vol. 19, no. 12, pp. 1299-1308. doi: 10.1038/s41590-018-0231-y
  12. Kao K.C., Chang K.W., Chan M.C., Liang S.J., Chien Y.C., Hu H.C., Chiu L.C., Chen W.C., Fang W.F., Chen Y.M., Sheu C.C., Tsai M.J., Perng W.C., Peng C.K., Wu C.L., Wang H.C., Yang K.Y. Predictors of survival in patients with influenza pneumonia-related severe acute respiratory distress syndrome treated with prone positioning. Ann. Intensive Care, 2018, vol. 8, no. 94, pp. 1-9. doi: 10.1186/s13613-018-0440-4
  13. Longini I.M. Jr., Halloran M.E., Nizam A., Yang Y. Containing pandemic influenza with antiviral agents. Am. J. Epidemiol., 2004, vol. 159, no. 7, pp. 623-633. doi: 10.1093/aje/kwh092
  14. Smeeth L., Cook C., Thomas S., Hall A.J., Hubbard R., Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet, 2006, vol. 367, no. 9516, pp. 1075-1079. doi: 10.1016/S0140-6736(06)68474-2

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Voloshchuk L.V., Go A.A., Pisareva M.M., Guzhov D.A., Bichurina M.A., Petrova P.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies